Dr. Aysegul Sahin is an internationally recognized breast pathology expert who is a faculty member at M. D. Anderson Cancer Center since 1988. She received her medical doctor degree from University of Ankara in 1980, completed Anatomic and Clinical Pathology Residency at Oregon Health Science University, and did Surgical and Oncologic Surgical Pathology Fellowships at the University of Iowa Hospital and Clinics and the UT M. D. Anderson Cancer Center. Currently, she is the Section Head of Breast Pathology and Director of Education in the Department of Pathology and Breast Pathology Fellowship Program. She is also the Director of the Breast Tumor Bank. Dr. Sahin is actively involved with clinical and translation research programs related to breast cancer. She has published over 310 peer-reviewed manuscripts on breast pathology especially on morphologic features of invasive and in-situ carcinomas, and high-risk lesions biomarkers of breast cancer progression, prognostic and predictive marker evaluations in breast cancer. Dr. Sahin has also published multiple book chapters on pathology of breast lesions. She is an executive committee member of International Society of Breast Pathology and member of national and international pathology societies
Dr. Chaitanyanand B. Koppiker, M.D. a Breast Oncoplastic Surgeon and the Medical Director of Orchids Breast Health Center, Pune, India. His was trained at B.J. Medical College, Pune and at the Tata Memorial Hospital, Mumbai. Thereafter he completed a Surgical Fellowship in Breast Oncoplastic Surgery (OBS) at the (Klinik für Senologie und Brustchirurgie Brustzentrum am Marien Hospital Düsseldorf Germany and St George Hospital Sydney, (Australia ) and has been trained in several international workshops in OBS.
Dr Koppiker established the 1st integrated cancer center in Pune ( Budhrani Cancer Institute at the Inlaks and Budhrani Hospital, Pune). He then served as the Director of the Ruby Hall Clinic Cancer Center and the Cancer Clinic and Research Center at Jehangir Hospital in Pune. He has then established a center of excellence for breast Health a unique facility with integrated solutions for breast care – ORCHIDS BREAST HEALTH.
He has attended as Faculty and Trainer in Oncoplastic surgery several National and international workshops. He has been an invited faculty at the Ameriacn Society Of Breast Diseases wprkshop on Oncoplastic Surgery , East Anglia University’s Mastership Program and several National workshops and conferences.
Dr. Koppiker’s current professional interests include:
Clinical Practice: Orchids Breast Health Center, Pune – a center of excellence providing integrated breast cancer medical services and patient care.
Medical Education and Training: Convener of International School of Breast Oncoplasty jointly with the Association of Breast Surgeons, UK and University of East Anglia, UK.
Medical Research : Director of Prashanti Research Foundation , an Oncology research group with focus on translational research in cancers affecting women
Community Service: Founder and Managing Trustee of Prashanti Cancer Care Mission, a non-profit, NGO providing affordable medical care and rehabilitation to cancer patients.
For his contribution to fighting Breast Cancer in India, Dr. Koppiker has been widely felicitated by numerous recognitions and awards by his medical peers as well as by various social organizations.
Dr Tanweer Shahid is a Senior Consultant Radiation Oncologist working at Apollo Gleneagles Hospital Kolkata.
He has done his post-graduation in 2007 and his Senior Residency from Tata Memorial Hospital, Mumbai.
His main interest is Breast and Head and Neck Cancer. He also has significant work in paediatrics brain tumours.
His major publication is in head and neck cancer.
He has received many fellowships and grants.
At present his major ongoing work is in radiotherapy of breast by hypofractionation schedules.
Nagi S. El-Saghir, MD, FACP is Professor of Clinical Medicine and Director of Breast Center of Excellence, Division of Hematology Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute, American University of Beirut Medical Center.
Dr. El Saghir graduated from Universite Libre de Bruxelles, completed his training in Internal Medicine at The Brooklyn Hospital-State University of New York, Hematology Oncology at St. Luke’s Roosevelt Hospital Center-Columbia University College of Physicians & Surgeons in New York, and is certified by the American Boards of Internal Medicine and Medical Oncology. He joined the clinical faculty as Clinical Instructor at State University of New York SUNY-Downstate at Long Island College Hospital and Brooklyn Hospital in New York. He worked as Acting Head of Hematology Oncology at King Khalid University Hospital, before returning to the USA where he practiced at Oakwood Hospital and was Clinical Assistant Professor at Wayne State University. Since he returned to Lebanon and joined AUBMC in 1993, Dr. El Saghir has built a very busy clinical practice along with a very productive career in teaching and research, as well professional and community services in Lebanon, Arab Countries and worldwide.
He is Director of the Breast Center of Excellence and leads the Multidisciplinary Breast Tumor Boards at AUBMC, Founding President of the Lebanese Society of Medical Oncology (LSMO), Past-President of the Lebanese Society of Internal Medicine, Past-Chair of International Affairs Committee of the American Society of Clinical Oncology (ASCO), Co-Chair of ASCO Guidelines Advisory Group for ASCO Clinical Practice Guidelines Committee, member of European Society of Medical Oncology ESMO Emerging Countries Committee, past National and Regional Representative ESMO, ESMO Developing Countries Task Force, ESMO/ASCO Global Curriculum Committee, ASCO Global Oncology Task Force, Official Nominee for ASCO Board of Directors, Co-Chair and Panel Member Breast Health Global Initiative (BHGI), Member of the Board of the Arab Association Against Cancer, and President of the Lebanese Breast Cancer Foundation.
Dr. El Saghir has over 100 publications in peer-reviewed journals and textbooks. His research is focused on breast cancer and young women, genetic mutations, awareness, early detection and screening, locally advanced and metastatic breast cancer, multidisciplinary management, treatment guidelines, multidisciplinary management and international phase III clinical trials. He published pioneering articles on epidemiology of cancer in Lebanon and Arab countries, locally advanced breast cancer, breast cancer in developing countries, BRCA mutations and resource-stratification guidelines. He is a Panel member and Co-author of ABC1, ABC2 and ABC3 International Consensus Guidelines for Advanced Breast Cancer published in The Breast and Annals of Oncology, Co-author of Resource-stratified Guidelines for Breast Cancer management (BHGI) published in Cancer, Breast Journal, The Breast, and Lancet Oncology. He is a regular speaker at Lebanese, Arab and international conferences including ASCO, ESMO, EBCC, ABC, BHGI and San Antonio as well as Pan Arab Cancer Congresses and Beirut Breast Cancer Conferences BBCC. He serves as regular peer reviewer, Deputy Editor for The Breast (2006-2013), Editorial Board Member of The Breast, ASCO’s Journal of Global Oncology JGO, ASCO Post and International Editor of Journal of Clinical Oncology JCO. He is also a regular contributor to ASCO Connection.
Dr. El Saghir is a recognized leader in cancer management and breast cancer expert in Lebanon and worldwide. He founded the Lebanese Society of Medical Oncology in 1997. He established monthly CME conferences and annual LSMO meetings since 1997. He chaired and is a regular speaker at Pan Arab Cancer Conferences Scientific Committees. He initiated and chaired annual post-ASCO meetings (ASCO Highlights in 1997 soon after the Annual ASCO meeting in Denver, Colorado that year; ASCO highlights meeting evolved into ASCO-sponsored Best of ASCO annual meetings of which he was one of the first to bring them to the International Scene to Tokyo, Mexico and Beirut since 2006).
Dr. El Saghir is author of “ABC of Breast Diseases” in Arabic and Awareness Booklet “Knowledge Road Map to Cure”. His professional and community services also include active involvement to ASCO, ESMO and BHGI efforts to reduce disparities in cancer management and outcome worldwide. He leads major breast cancer awareness campaigns and has appeared in over 500 TV and press interviews. His research, publications, media interventions, books, and community activities, along with his colleagues, are recognized to have led to significant down-staging of breast cancer in Lebanon and improved patients’ outcome for which has received the Medal of Honor for Achievements in 2002 and the National Cedar Medal of Honor - Rank Officer (2014) from the Presidents of Lebanon, Excellence in Cancer Research Prix 2015 du Centre National de Recherche Scientifique CNRS of Lebanon, awards from LSMO, Lebanese Order of Physicians, Cairo University, League of Womens’ Rights and many others. @NagiSaghir, www.facebook.com/ Nagi El Saghir , www.saghironline.com, www.aub.edu.lb
Born and educated in Johannesburg, South Africa, I completed my medical training through the University of the Witwatersrand Medical School in 1992.
As a qualified Diplomate in Anesthesia, I then completed my Radiology Fellowship with the College of Radiology South Africa and developed a keen interest in women’s imaging, specifically breast.
I joined Mediclinic Middle East in 2008 on arrival in Dubai.
With their support, I established the first dedicated breast imaging unit in the private sector offering patients the complete range of screening and diagnostic services including state of the art imaging and interventional services.
Stephen Johnston is Professor of Breast Cancer Medicine and Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London. He was the first Director of the UK’s National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer at the Royal Marsden. He graduated in 1983 from Trinity College at The University of Cambridge, and in 1986 from The Medical School at The University of Newcastle upon Tyne. He trained in General Medicine at St Bartholomew's Hospital and Hammersmith Hospital in London, and subsequently in Medical Oncology at the Royal Marsden Hospital. He gained his PhD from the Institute of Cancer Research at the University of London, and took up his current position as Medical Oncologist on the Breast Unit at the Royal Marsden Hospital in 1997. He has a specialist interest in the treatment of metastatic breast cancer, and his major research interests lie in understanding mechanisms of endocrine resistance in breast cancer. He is actively involved in facilitating the interface between basic and applied research, and is chief investigator of several phase II / III trials of novel therapeutic approaches in advanced disease, including new endocrine therapies and targeted signal transduction inhibitors. He has published over 230 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national & international meetings. He is a member of several scientific committees and advisory boards, a Faculty Member at the American Society for Clinical Oncology, the Deputy-Editor of the international journal ‘Breast Cancer Research’, and a former Trustee of the UK charity ‘Breast Cancer Campaign’ having also been Chairman of their Scientific Advisory Board.
Hamdy A. Azim is a Professor of Clinical Oncology at Cairo University in Egypt. He finished his doctorate degree on the management of non-Hodgkin's lymphoma in adults (1986). Dr Azim then obtained postdoctoral training at the Medical Oncology Department in NCI- Milan ( 1987) , the Medical Oncology Department in Curie Institute -Paris, France ( 1988-1989) , and at the Department of Adult Lymphoma and Bone Marrow Transplants, St. Louis Hospital in Paris( 1996) Dr Azim is a member of numerous societies including ASCO, ASH, ESMO , the European Blood and Marrow Transplantation Society (EBMT), and the American Society of Therapeutic Radiology (ASTRO). He sits on several international scientific / steering committees and has been invited as a speaker in more than 300 regional and international conferences. He also served as a speaker for the ASCO online educational programme. His main interests lie in breast cancer, molecular target therapies , bone metastases , Lymphoma and translation research where he has published more than 70 papers and 400 abstracts. Dr. Azim has been a principle investigator of many Multicenter international clinical trials mainly in breast cancer Dr Azim is an editor for the Journal of Clinical Lymphoma, The Lancet (Middle East edition), and the Journal of Clinical Oncology and Nuclear Medicine Cairo university. He was the chief editor of 2 educational books ( ASCO – PANARAB Lymphoma , 1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006). Dr Azim serves as a referee for the Annals of Oncology Journal, THE BREAST , Chemotherapy Journal , Advances in Cancer Research and Journal of the Egyptian National Cancer Institute. He has been honoured with several awards including Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002), the Order of Merit, Cambridge University (2002), the Best Arab Oncologist from the Lebanese Society of Medical Oncology (LSMO,2004) and the recognition award for significant contribution to the Oncology field in the middle east from UAE (Dubai -2013)
Dr Azim was the first to represent the Middle Eastern Region on the ASCO International Affairs Committee from 1997 to 2002. Together with international cancer research leaders, and the French president J. Chiraque, Dr Azim signed the “Charter of Paris against Cancer” on behalf of the Arab World in February 2000. On 2008, Dr. Azim was nominated as the chairman of the steering committee of the NCCN Middle East , which is responsible to set the guide lines of the management of certain cancers in the region. On January 2012 , Dr. Azim was elected to serve as the chairman of the department of clinical oncology ,faculty of medicine,Cairo University
Dr Houriya Kazim is a UAE national who is the country's first lady surgeon. She attended medical school at the Royal College of Surgeons in Ireland, obtained her fellowship in General Surgery then sub-specialized in Surgical Oncology and, in particular, Breast Surgery and reconstruction at the Royal Marsden Hospital in London.
She has her own practice in Dubai at the Well Woman Clinic, which she set up in 2006. In addition to her clinical work, she founded and runs the only breast cancer support group in the city called "Brest Friends" and has also founded, and chairs, a breast cancer charity by the same name. She is a freelance writer on women's health issues and is married to an American television journalist. They are parents to two daughters aged 9 and 11 years old.
Mohsen Mokhtar is Professor of Clinical Oncology at the Cairo University Kasr El Aini Medical School in Egypt.
Professor Mokhtar obtained his B. Sc. in Medicine in 1991, his M. Sc. in Clinical Oncology, Chemotherapy and Radiotherapy treatment, in 1996, and his MD in Clinical Oncology, Chemotherapy and Radiotherapy treatment, in 2001, all from the Cairo University Kasr El Aini Medical School.
Professor Mokhtar started his career as Assistant Lecturer in Clinical Oncology in 1996. He became Lecturer in Clinical Oncology in 2001, Assistant Professor of Clinical Oncology in 2006, and was appointed Professor of Clinical Oncology in 2011. He developed syllabus and overall course structure with clinical attachment and supervised numerous PhD students.
Professor Mokhtar acted as scientific coordinator for many regional and international conferences. He is also an active member of the Arab Medical Association against Cancer (AMAAC), the Egyptian Cancer Society (ECS) and the Egyptian Hematology – Oncology Group (EHOG).
Professor Mokhtar’s research focuses on breast, ovarian malignancies and prostate cancer. He published more than 50 publications on these topics in regional magazines. He also collaborated to several regional and international trials
Dr Shona Nag completed training in Medical Oncology from Tata Memorial Hospital, Mumbai and St George Hospital, Sydney. She is currently practising in Pune as Senior Oncologist in the Dept of Oncology at Jehangir Hospital and Prime Surgical .Dr Nag has conducted a tumour board at the Sassoon general Hospitals from 2003-2010. She currently is attached as Honorary Oncologist to KEM Hospital Mumbai. Dr Nag is Principal Investigator for over 55 global clinical trials, most of these have been in breast cancer. She has numerous publications and presentations to her credit.
In 2010, Dr Nag was awarded the best principal investigator for clinical research in India by ISCR (a national body). The same year she was also awarded the GSK – Ethnic Research initiative for breast cancer research in developing countries.
She is a member of several International Cancer Societies and ICON (Indian Collaborative Oncology network) and has been on several advisory boards and DSMB’s for drug development in the country.
Her special areas of interest are women cancers. She is also involved in cancer prevention through awareness campaigns and public lectures. Dr Nag is a Trustee of the Nag Foundation, an NGO involved in Cancer care, Research and Education and a co-founder of a support group called BreastFriendsPune which is involved in survivorship aspects of breast cancer care.
Dr. Salim Chaib Rassou; was graduated as Medical doctor on 1988, Constantine ALGERIA. He obtained his specialist diploma with outstanding rate on 1992, from Bourgogne University under supervision of Pr J.C Horiot. Post graduation Diplomas, one in breast diseases and another in breast imaging. He worked in different hospitals in France and hold different positions as senior staff.
He took part in different phase III trials as investigator, mainly in head and neck cancer, breast cancer, lung cancer... He passed with success the French national competitive for (praticien Hospitalier) and holds this position 3 years.
Keeping in touch with all the new development in Radiation Therapy, by attending several courses and congress (average of more than 200 CME hours per year). His main interest, H&N, Gynaecology, Breast and Brain tumours Co-author of 3 major’s publications and 5 abstracts.
After introducing 3 D CRT in all cancer localisation in his previous position, he started a new challenge at AHD by introducing state of the art radiotherapy technique with RapidArc and Breast Gated IMRT and in charge of developing new other techniques such Stereotactic Radiosurgery and HDR Brachytherapy project for 2012
Professor Peter Schmid was appointed as Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London, in 2013. He is Clinical Director of Breast Cancer at the St. Bartholomew Cancer Centre and Honorary Consultant Medical Oncologist at Barts Hospital. Professor Schmid is also Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute and the Barts/Brighton Experimental Cancer Medicine Centre. He leads the academic breast cancer programme and the cancer immune therapy group at Barts Cancer Institute.
Professor Schmid trained in medicine at Ludwig-Maximilians-University Munich, Technical University of Munich and University of Aberdeen. He was awarded scholarships by the 'Studienstiftung des deutschen Volkes', the 'Hanns-Seidel-Foundation', and the 'Deutscher Akademischer Austauschdienst'. Professor Schmid completed a MD on mitochondrial creatine kinase at the Technical University Munich. He subsequently trained at the University Hospital Charité in Berlin in internal medicine, haematology and oncology, where he became head of breast cancer research and the phase I programme. He completed his PhD at the Charité University in Berlin in 2005 and was awarded the "habilitation and venia legendi" and an external readership by the Charité University in 2006. From 2005-2010, Prof. Schmid was a Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London. In 2010, he was appointed as Foundation Chair in Cancer Medicine at the University of Sussex, and he was Director of the Clinical Investigation and Research Unit at Brighton and Sussex University Hospitals until his move to Barts.
Professor Schmid’s specialist cancer interests are breast cancer, cancer immune therapy and early drug development. His research interests lie in stratified cancer medicine utilising novel biomarkers and innovative, biomarker-driven clinical trial strategies to develop new treatment strategies. Professor Schmid has successfully led more than 20 national/international academic clinical studies, ranging from phase I to III, and several translational research programmes. He leads a collaborative group to establish circulating tumour DNA as a biomarker and is principal investigator of 2 ongoing, prospective international biomarker studies on predictive epigenetics from circulating tumour DNA.
Professor Schmid is a member of several national and international cancer organizations and research groups and has been involved in international consensus meetings on the management of breast cancer. Professor Schmid is a member of ESMO breast cancer Faculty, the UK NCRN breast cancer study group and of the breast cancer and translational research steering groups of the German cooperative group of medical oncology. He has authored or –co-authored 165 publications and has published a book on the management of bone metastases (3rd edition).
Dr. Nadia Malik obtained her American Board Certification in Radiation Oncology in 2013. She did her basic medical training from North East Ohio Medical University, Rootstown Ohio, USA in 2007. Prior to joining us, Dr. Malik worked since November, 2014 as a Consultant Radiation Oncologist at Gulf International Cancer Center. From September, 2012 to July, 2014 she worked as an Assistant Professor Radiation Oncology at Roswell Park Cancer Institute Buffalo New York, USA.
Dorria Salem 1953, Egyptian radiologist, MD, Cairo University 1987. A professor at Cairo University teaching hospital, since 1998 and the general manager of the women's health outreach program [National Egyptian breast screening program] since 2007. She is one of the pioneers in the women's imaging the thing that put her in a very distinguished position on the national level as well as the Arab level. She is the founder of the women's imaging unit at the radiology department at Cairo university teaching hospital since 2003. She is also a member of the continuous teaching program of Cairo University and the ministry of health and population. She has recently been selected to be a member in the Middle East board of Aunt Minnie radiology website.
Dr Sudeep Gupta, completed his MBBS, MD and DM from All India Institute of Medical Sciences, New Delhi, in the year 2000 and has been a faculty member in the Department of Medical Oncology at Tata Memorial Centre since then. He has been a prolific clinical researcher who is actively involved in planning, organizing, conducting and analyzing Phase I, II and III clinical trials and has been a Principal Investigator or Co-investigator in more than 100 trials. He takes special interest in breast and gynecological cancers and early drug development. His research areas have involved implementation science including access to medications, guideline development, testing concepts and technology in clinical trials, innovative therapeutic strategies, toxicity and quality-of-life studies, pharmacokinetics and translational studies involving next-generation sequencing technology. He has published more than 120 papers in peer reviewed journals.
Since 2013 he has been the Deputy Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) one of the premier cancer translational research centres in India. He is currently engaged in facilitating cross talk between various stakeholders in cancer research at the institutional and national level, including basic scientists, clinical researchers, computational biologists, physicists, engineers and others.